FOR IN VITRO RESEARCH & LABORATORY USE ONLYNOT FOR HUMAN OR VETERINARY USECASH ON DELIVERY AVAILABLEFOR IN VITRO RESEARCH & LABORATORY USE ONLYNOT FOR HUMAN OR VETERINARY USECASH ON DELIVERY AVAILABLE
SLU-PP-332 by SwissChems - 60 capsules × 100mg
Have questions?Get instant help from our team
ORAL CAPSULE / SwissChems

SLU-PP-332 - SwissChems - 60 capsules × 100mg

Buy SLU-PP-332 60 caps in India — SwissChems Research Grade

SLU-PP-332 - Exercise Mimetic Pan-ERR Agonist

→ View SLU-PP-332 buying guide for India

Synthetic small-molecule pan-estrogen-related receptor (ERR) agonist developed at Saint Louis University. Activates exercise-mimetic metabolic pathways without physical activity. Strict research-only, no human dose established.

In Stock
Lab Verified
High Purity
Made in USA
Oral Capsule

Order this product

Sealed Bottle
₹5,300

Factory-sealed bottle of 60 capsules / bottle. Ready for immediate dispatch.

🚚 Pan-India delivery  /  Cash on Delivery available

Why researchers reach for SLU-PP-332

Mitochondrial biogenesis

Drives PGC-1α-mediated mitochondrial proliferation - the cellular foundation of exercise adaptations.

Fatty acid oxidation

Activates the metabolic pathway that burns fat for energy - preclinical models showed 12% body weight loss in 28 days.

Endurance capacity

Animal studies showed 70% increase in exercise endurance - the standout finding behind the "exercise mimetic" label.

Cardiac and renal protection

Pep-pedia's research summary cites cardiac protection and reversal of age-related mitochondrial dysfunction in preclinical models.

Community Insights

Self-reported by pep-pedia.org users and published research summaries. Not clinical evidence.

72%
Effectiveness
of 87 respondents
64%
Would Recommend
of 119 respondents
Side effects No human safety data Animal studies show favourable profile Research compound only
Best results 4–8 weeks

How SLU-PP-332 Works

01

ERR pan-activation

Binds and activates all three ERR isoforms (α, β, γ) with preferential ERRα activity - orphan nuclear receptors that govern energy metabolism.

02

PGC-1α-driven biogenesis

Activated ERRs drive PGC-1α-coordinated transcription of mitochondrial biogenesis genes - the same programme exercise activates.

03

Fat oxidation and energy expenditure

Mitochondrial expansion plus upregulated fatty-acid oxidation enzymes shifts metabolism toward fat as fuel - the exercise-mimetic phenotype.

Mechanism summary sourced from pep-pedia.org and the published peptide research literature.

Stack It With

Full Specifications
Peptide
SLU-PP-332
Brand
SwissChems
Sequence
Small-molecule compound (not a peptide)
Molecular Weight
478.5 g/mol
CAS Number
Research compound
Half-Life
Animal data only - short (preclinical)
Typical Dose
50 mg/kg in animal research (NO HUMAN DOSE ESTABLISHED)
Cycle Duration
4–8 weeks (preclinical)
Dosage
100mg per capsule
Quantity
60 capsules / bottle
Form
Oral capsule
Storage
Cool, dry place; protect from light
Intended Use
Research use only - not for human consumption

Frequently Asked Questions

Has SLU-PP-332 been tested in humans?

No. Per pep-pedia, SLU-PP-332 has tremendous preclinical promise but no human clinical trials. There is NO established human dose. The 50 mg/kg figure is animal-research dosing only.

Why is it called an "exercise mimetic"?

It activates ERRα/PGC-1α - the same metabolic transcriptional programme exercise activates. Animal models showed exercise-equivalent effects (mitochondrial biogenesis, fat oxidation, endurance gains) without physical activity. The term "exercise mimetic" captures this.

Is SLU-PP-332 a peptide?

No - it's a small-molecule compound, not a peptide. We carry it because it overlaps with peptide research interests in metabolism and mitochondrial function. The oral capsule format reflects its small-molecule nature.

Will it appear in athletic drug tests?

WADA prohibition status is uncertain because SLU-PP-332 is so new. Researchers should assume any exercise-mimetic compound will eventually be tested for and avoid use in competitive contexts.

Why oral capsules instead of injectable?

SLU-PP-332 is a small-molecule compound with reasonable oral bioavailability - animal models used oral dosing. Capsule format is consistent with how the molecule is used in published preclinical research.

Ready to order

SLU-PP-332 - SwissChems

₹5,300 · 60 capsules × 100mg · Oral capsule · Pan-India delivery

Add to Cart

Research Use Only

This product is intended solely for laboratory and research purposes. It is not intended for human consumption, therapeutic use, or as a food or drug product. By purchasing, you confirm that this product will be used exclusively for legitimate research applications.

Read all customer reviews →